About GENVAX TECHNOLOGIES INC
Genvax Technologies is a startup animal vaccine company based in Ames, Iowa, focused on developing next-generation mRNA + nanoparticle vaccines for the prevention and treatment of animal diseases. The company was founded in 2021 by Dr. Hank Harris and Joel Harris, who previously sold Harrisvaccines to Merck Animal Health in 2015.
Development of next-generation mRNA + nanoparticle vaccinesCustom herd-specific vaccines with traceable dataRapid variant updating capabilitiesSustainable production methodsUtilization of existing cold chain distribution efforts
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to GENVAX TECHNOLOGIES INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.